EU TRANSPARENCY REGISTER · 494574538937-86 · Netherlands

Centrient Pharmaceuticals International B.V.

Category

Companies & groups

Country

Netherlands

Delft

Entity form

Registered Private Limited Company (B.V.)

Stated objectives

Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as …

As declared by the registrant. Truncated to 240 characters; full text on the upstream profile.

Official profile

The full record on the Joint Transparency Register carries financial information (lobby budget, EU funding received), the list of named accredited representatives, declared interests of those persons, and a history of meetings with Commission officials.

Registered

2020-07-13

Last updated

2025-11-24

Other Companies & groups in Netherlands

Other registered organisations in Netherlands

Frequently asked questions

What is this organisation?
Centrient Pharmaceuticals International B.V. is an interest representative listed in the EU Joint Transparency Register under ID 494574538937-86. Entity form: Registered Private Limited Company (B.V.).
What category is it registered under?
It is registered under the category "Companies & groups".
Which country is it based in?
The organisation is based in Netherlands, Delft.
What are its stated goals?
As declared by the registrant: Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as …
Where can I find its EU Transparency Register entry?
The full register entry — including lobby budget, EU funding received, accredited representatives and Commission meetings — is available on the EU Transparency Register under ID 494574538937-86.

Source: EU Joint Transparency Register (Council / Commission / Parliament) · refreshed 2026-07-03 · Commission Reuse Decision 2011/833/EU